Hillard Lazarus
About
In The Last Decade
Hillard Lazarus
17 papers receiving 693 citations
Peers
Comparison fields: 5 of 76
- Hematology 345
- Public Health, Environmental and Occupational Health 256
- Molecular Biology 220
- Oncology 163
- Genetics 65
Countries citing papers authored by Hillard Lazarus
This map shows the geographic impact of Hillard Lazarus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hillard Lazarus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hillard Lazarus more than expected).
Fields of papers citing papers by Hillard Lazarus
This network shows the impact of papers produced by Hillard Lazarus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hillard Lazarus. The network helps show where Hillard Lazarus may publish in the future.
Co-authorship network of co-authors of Hillard Lazarus
This figure shows the co-authorship network connecting the top 25 collaborators of Hillard Lazarus. A scholar is included among the top collaborators of Hillard Lazarus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hillard Lazarus. Hillard Lazarus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 6 | |
| 3 | 55 | |
| 4 | 39 | |
| 5 | 1 | |
| 6 | lymphoblastic leukemia regimen enhances long-term outcomes in Philadelphia positive acute UKALLXII/ECOG2993: addition of imatinib to a standard treatment | 1 |
| 7 | 246 | |
| 8 | 197 | |
| 9 | 25 | |
| 10 | 10 | |
| 11 | 4 | |
| 12 | 5 | |
| 13 | 19 | |
| 14 | 1 | |
| 15 | 21 | |
| 16 | Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies. | 14 |
| 17 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.